β-elemene promotes the senescence of glioma cells through regulating YAP-CDK6 signaling

In this article, we found that a mistake happened during figure organization: the same typical images of C6 cells treated with 10 μg/ml β-elemene for 2 days were inadvertently shown in both Figure 1A and 1G. So, we would like to publish this Erratum to reflect this change. The error does not change the scientific conclusions of the article. We would like to apologize for the errors and any inconvenience caused.

Figure 1.

β-elemene promoted the premature senescence of C6 cells. (A) Representative images of C6 cells in the bright field treated with control or different concentrations of β-elemene for 1 day or 2 days. (B-D) The effects of β-elemene (treated at 10 μg/mL, 50 μg/mL, 100 μg/mL and 200 μg/mL for 1 day) on U87 (B), DBTRG (C) and C6 (D) cell viability detected by CCK8 (n=5). (E) Representative images of SA-β-Gal staining of C6 cells treated with control or different concentrations of β-elemene for 1 day or 2 days. (F) Quantification of the percentage of SA-β-Gal⁺ C6 cells over total cells as shown in (E) (n=15). (G) Representative images of C6 cells in the bright field treated with control or 10 μg/mL β-elemene for 1, 2, 4, 6, 8, or 10 days. (H) Representative images of SA-β-Gal staining of C6 cells treated with control or 10 μg/mL β-elemene for 2 days. (I) Quantification of the percentage of SA-β-Gal⁺ C6 cells over total cells as shown in (H) (n=15). D, day. Scale bars, 20 μm. Data were mean ± s.e.m, *P < 0.05, **P < 0.01, ***P < 0.001.

The corrected Figure 1 is as follows.